![Ameet Mallik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ameet Mallik
Amministratore Delegato presso
ADC THERAPEUTICS SA
Patrimonio netto: 3 M $ in data 31/10/2026
Profilo
Ameet Mallik currently works at ADC Therapeutics SA, as President, Chief Executive Officer & Director from 2022.
Mr. Mallik also formerly worked at Cornerstone Pharmaceuticals, Inc., as Non-Executive Chairman, Rafael Holdings, Inc., as Director in 2022, Atara Biotherapeutics, Inc., as Independent Director from 2021 to 2025, Novartis Oncology, Inc., as Global Head-Marketing, Value & Access from 2015 to 2017, Novartis AG, as Executive Vice President & Head-US Oncology from 2017 to 2021, McKinsey & Co., Inc., as Associate Principal, and Sandoz International GmbH, as Head-Biopharmaceuticals & Oncology Injectables from 2009 to 2014.
Mr. Mallik received his undergraduate degree and graduate degree from Northwestern University and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ADC THERAPEUTICS LTD 1,66% | 30/06/2026 | 2.121.769 ( 1,66% ) | 3 M $ | 31/10/2026 |
| 10/06/2025 | 16.928 ( 0,17% ) | 135 593 $ | 31/10/2026 |
Posizioni attive di Ameet Mallik
| Società | Posizione | Inizio |
|---|---|---|
| ADC THERAPEUTICS SA | Amministratore Delegato | 09/05/2022 |
Precedenti posizioni note di Ameet Mallik
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Direttore/Membro del Consiglio | 03/09/2025 |
| RAFAEL HOLDINGS, INC. | Amministratore Delegato | 01/02/2022 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | 01/11/2015 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | 01/04/2014 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formazione di Ameet Mallik
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops anti-cancer drug delivery technology | Commercial Services |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
